check_circleStudy Completed

Ischemia, Cerbral

Bayer Identifier:

Trial_0178

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Cerebral blood flow (CBF) with 40, 60 and 80 mg of Nimodipine.

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

17 - 67 Years
  • -

  • -

Trial summary

Enrollment Goal
48
Trial Dates
January 1982 - December 1982
Phase
N/A
Could I Receive a placebo
N/A
Products
Nimotop (Nimodipine, BAYE9736)
Accepts Healthy Volunteer
N/A

Trial design

Preliminary presentation of all the cerebral blood flow (CBF) measurements included in the final evaluation with 40, 60 and 80 mg of Nimodipine
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A